Gemcitabine (Hospira, Inc.)
Welcome to the PulseAid listing for the Gemcitabine drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | GEMCITABINE |
SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-07-09 |
END MARKETING DATE: | 0000-00-00 |
Gemcitabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Gemcitabine from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 38(mg/mL) |
START MARKETING DATE: | 2013-07-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-0181_695ba2a9-02bc-4b66-867d-aa2dd21ee588 |
PRODUCT NDC: | 0409-0181 |
APPLICATION NUMBER: | NDA200795 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: